(Q45847558)

English

A randomized trial on the acute and steady-state effects of a new antidepressant, vortioxetine (Lu AA21004), on actual driving and cognition

scientific article published on 20 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

A randomized trial on the acute and steady-state effects of a new antidepressant, vortioxetine (Lu AA21004), on actual driving and cognition (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

1 reference

ChEBI release 2020-05-28

author name string

E L Theunissen

1

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

D Street

2

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

A-M Højer

3

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

A Vermeeren

4

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

A van Oers

5

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

J G Ramaekers

6

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

language of work or name

0 references

publication date

20 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

93

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

6

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

493-501

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

Effects of antidepressants on cognitive functions: a review

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Cognitive deficits in depression: possible implications for functional neuropathology

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Productivity losses among treated depressed patients relative to healthy controls

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Absenteeism among employees treated for depression.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Cognitive toxicity of pharmacotherapeutic agents used in social anxiety disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Diazepam impairs lateral position control in highway driving.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Effects of mefloquine alone and with alcohol on psychomotor and driving performance.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

A Review of the Pharmacological and Clinical Profile of Mirtazapine

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Tolerability and safety aspects of mirtazapine

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

A placebo controlled investigation into the effects of paroxetine and mirtazapine on measures related to car driving performance.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Effects of moclobemide and mianserin on highway driving, psychometric performance and subjective parameters, relative to placebo

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

A dose-ranging study of the effects of mequitazine on actual driving, memory and psychomotor performance as compared to dexchlorpheniramine, cetirizine and placebo

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Microcomputer analyses of performance on a portable, simple visual RT task during sustained operations

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

P.2.b.015 Lu AA21004: a novel potential treatment for mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Psychoactive medications and injurious motor vehicle collisions involving older drivers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Considering the P450 cytochrome system as determining combined effects of antidepressants and benzodiazepines on actual driving performance of depressed outpatients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CLPT.2013.39

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45847558&oldid=2086231649"